Clinical Trial Update: Role of AST120 for Sarcopenia Prevention in Pre-dialysis Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating AST120 for prevention of sarcopenia in pre-dialysis chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• AST120

Snippet

Sponsor: Gumi Cha Medical Center | Conditions: Chronic Kidney Diseases | Phase 4 | Status: COMPLETED